Sunday, February 14, 2021 10:07:46 PM
Sukus:
Thank you very much for your kind words.
I don’t give investment advice but I like to contribute ideas that may stimulate thinking and feed back for my own benefit as well as that of fellow members. This is a very good board. There are a lot of great posters who perform excellent DD and articulate their opinions very well. This board is a very good source of information and a great sounding “board.”
I present my own views and if these are of help to others, that is great. I feel very strongly and positive about the results. For the reasons I have expressed at length I am not concerned——yet—- about the delay in TLD announcement. I don’t think this is due to nefarious machinations by NWBO management and their collateral family. Too many upstanding people are involved at this stage. Very difficult if impossible to pull a scam or hide less favorable results in hopes of manufacturing excuses around them. The info we already have points to trial success. However, the silence hopefully for good reason allows manipulators to play with the stock. And they will continue because now they can. As an accredited investor, whenever I speak with management, they are upbeat and confident. It is very hard to sustain such a facade, IMHO.
I believe the science is solid. There are three physicians in my immediate family to whom I have recommended they look into NWBO. They are invested but to what degree I don’t know. None of my business but they are persuaded by the science just like our wise board member, Iwasadiver. I think we are in good company FWIW.
GLTA.
Thank you very much for your kind words.
I don’t give investment advice but I like to contribute ideas that may stimulate thinking and feed back for my own benefit as well as that of fellow members. This is a very good board. There are a lot of great posters who perform excellent DD and articulate their opinions very well. This board is a very good source of information and a great sounding “board.”
I present my own views and if these are of help to others, that is great. I feel very strongly and positive about the results. For the reasons I have expressed at length I am not concerned——yet—- about the delay in TLD announcement. I don’t think this is due to nefarious machinations by NWBO management and their collateral family. Too many upstanding people are involved at this stage. Very difficult if impossible to pull a scam or hide less favorable results in hopes of manufacturing excuses around them. The info we already have points to trial success. However, the silence hopefully for good reason allows manipulators to play with the stock. And they will continue because now they can. As an accredited investor, whenever I speak with management, they are upbeat and confident. It is very hard to sustain such a facade, IMHO.
I believe the science is solid. There are three physicians in my immediate family to whom I have recommended they look into NWBO. They are invested but to what degree I don’t know. None of my business but they are persuaded by the science just like our wise board member, Iwasadiver. I think we are in good company FWIW.
GLTA.
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
